Baxter Buretrol Solution Sets Recalled Due to Risk of Air Embolism

|

Federal health regulators are warning that Baxter Buretrol Solution Sets are being recalled because a defective ball-valve could let air into a patient’s blood, posing a serious risk of an air embolism. 

This week the FDA classified a Baxter Buretrol Solution Set market withdrawal as a class 1 medical device recall, which is the most serious category of medical device recalls. This suggest that the FDA believes the problem is likely to result in severe injury or death.

The Buretrol Solution Sets are disposable devices used to control the flow of fluids into a patient’s blood vessels via an intravenous device. They were originally recalled in early September, but this week the FDA determined it constituted the highest threat a medical device could pose to patients. However, there have been no reports of injuries or deaths linked to the defective solution sets.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The problem is a ball-valve feature that the FDA says might not function as expected. Baxter warns that it is allowing air to flow past the valve. From there the air can enter the tubing and be accidentally injected into the patient, resulting in an air embolism, which could lead to death.

The recall affects all lots of the Interlink System Buretrol Solution Set with 150 mL Burette with product code 2C7519, the Interlink System Buretrol Solution Set with 150 mL Burette – Non-DEHP, with product code 2H7519; the Clearlink System Buretrol Solution Set with 150 mL Burette with product code 2C8810, and the Clearlink System Buretrol Solution Set with 150 mL Burette – Non-DEHP. All of the affected medical devices were manufactured from April 30, 2003, through July 26, 2012.

Baxter Healthcare Corporation and the FDA are advising consumers to stop using affected Buretrol Solution Sets and contact Baxter for information on how to return the products by calling (800) 422-9837.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

Canadian researchers say receiving Depo-Provera injections for more than a year triples the risk of brain tumors compared to women who take birth control pills.
A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers.